Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-026797
Filing Date
2013-05-16
Accepted
2013-05-16 16:06:12
Documents
1
Period of Report
2013-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3961
  Complete submission text file 0001209191-13-026797.txt   5360
Mailing Address FIRST HORIZON PHARMACEUTICAL CORP 660 HEMBREE PKWY STE 106 ROSWELL GA 30076
Business Address
LAPALME PIERRE (Reporting) CIK: 0001114913 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35902 | Film No.: 13851301

Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Issuer) CIK: 0001516479 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations